摘要
目的体外建立人胃癌细胞多药耐药模型,研究多药耐药机制及三氧化二砷(As2O3)对其逆转耐药作用。方法采用阿霉素(ADM)浓度梯度递增法诱导建立人胃癌多药耐药细胞株SGC7901/ADM,MTT法检测SGC7901/ADM细胞对ADM、长春新碱(VCR)、紫杉醇(TAX)的敏感性及As2O3对其逆转耐药倍数,免疫细胞化学法(PV法)检测细胞P-糖蛋白(P-gp)、Caspase3表达,流式细胞仪检测细胞凋亡率。结果 SGC7901/ADM细胞对ADM、VCR和TAX均耐药,耐药倍数分别是7.49、7.56及5.33。在As2O3作用48h后,3种抗癌药物对SGC7901/ADM细胞生长抑制50%时的浓度(IC50)明显降低,差异有显著性(F=169.766-1 199.812,q=6.86-70.40,P〈0.01);耐药细胞经As2O3及环孢素A(CsA)作用后,P-gp表达明显下调,差异有显著性(F=42.870,q=7.70-21.50,P〈0.01);As2O3高浓度组细胞中Caspase3表达上调,差异有显著性(F=7.220,q=6.63,P〈0.05)。As2O3作用组SGC7901/ADM细胞凋亡率随As2O3浓度增加而增加(F=1 986.63,q=21.23-95.08,P〈0.05)。结论 SGC7901/ADM细胞具有多药耐药性,As2O3可逆转其耐药,并呈剂量依赖性。
Objective To establish A multidrug-resistant(MDR)cell model of gastric cancer in vitro,and study the effect of arsenic trioxide(As2O3)on MDR reversal. Methods MDR human gastric carcinoma cell line(SGC7901/ADM)was created in vitro by gradually increasing the density of adriamycin(ADM).MTT assay was used to determine the sensitivity of SGC7901/ADM to ADM,VCR and TAX,and the drug resistance reversal fold(DRRF)of As2O3 were determined by MTT method;PV-method was used to detect the expressions of P-gp and Caspase3;flow cytometry(FCM)was applied to check apoptosis rate in tumor cells. Results SGC7901/ADM cells were resistant to ADM,VCR and TAX with a drug resistance fold of 7.49,7.56 and 5.33,respectively.After intervention with As2O3 for 48hours,the IC50 for the three anti-cancer drugs significantly reduced in SGC7901/ADM(F=169.766-1 199.812,q=6.86-70.40,P〈0.01);P-gp expression levels(OD value)was significantly lower in As2O3 and CsA groups(F=42.870,q=7.70-21.50,P〈0.01);Caspase3increased in As2O30.5μmoL/L group(F=7.220,q=6.63,P〈0.05).Apoptosis rate was positively correlated with drug concentration and time(F=1 986.63,q=21.23-95.08,P〈0.05). Conclusion SGC7901/ADM cell lines show multi-drug resistance,As2O3 can reverse its drug resistance manifesting dose-dependent.
出处
《齐鲁医学杂志》
2014年第5期404-406,410,共4页
Medical Journal of Qilu
关键词
胃肿瘤
多药耐药相关蛋白质类
三氧化二砷
stomach neoplasms
multidrug resistance-associated proteins
arsenic trioxide